Overall Trading Platform
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Takeda Pharmaceutical Company Limited is a drug manufacturers-specialty & generic business based in the US. Takeda Pharmaceutical Company shares (TAK) are listed on the NYSE and all prices are listed in US Dollars. Takeda Pharmaceutical Company employs 47,495 staff and has a trailing 12-month revenue of around USD$3.2 trillion.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Since the stock market crash in March caused by coronavirus, Takeda Pharmaceutical Company's share price has had significant negative movement.
Its last market close was USD$16.62, which is 11.55% down on its pre-crash value of USD$18.79 and 33.71% up on the lowest point reached during the March crash when the shares fell as low as USD$12.43.
If you had bought USD$1,000 worth of Takeda Pharmaceutical Company shares at the start of February 2020, those shares would have been worth USD$689.01 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$858.42.
|Latest market close||USD$16.62|
|52-week range||USD$15.3 - USD$19.97|
|50-day moving average||USD$17.9235|
|200-day moving average||USD$17.6906|
|Wall St. target price||USD$22.75|
|Dividend yield||USD$180 (1077.84%)|
|Earnings per share (TTM)||USD$0.525|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-04-29)||-0.42%|
|1 month (2021-04-09)||-3.65%|
|3 months (2021-02-09)||-6.15%|
|6 months (2020-11-09)||-1.01%|
|1 year (2020-05-08)||-5.84%|
|2 years (2019-05-09)||-12.76%|
|3 years (2018-05-09)||-19.36%|
|5 years (2016-05-09)||-31.29%|
Valuing Takeda Pharmaceutical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Takeda Pharmaceutical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Takeda Pharmaceutical Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Takeda Pharmaceutical Company shares trade at around 32x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Takeda Pharmaceutical Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.1296. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Takeda Pharmaceutical Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Takeda Pharmaceutical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$781.4 billion.
The EBITDA is a measure of a Takeda Pharmaceutical Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$3,199.2 billion|
|Operating margin TTM||8.91%|
|Gross profit TTM||USD$2,201.5 billion|
|Return on assets TTM||1.41%|
|Return on equity TTM||3.8%|
|Market capitalisation||USD$53.1 billion|
TTM: trailing 12 months
There are currently 11.1 million Takeda Pharmaceutical Company shares held short by investors – that's known as Takeda Pharmaceutical Company's "short interest". This figure is 31.5% up from 8.4 million last month.
There are a few different ways that this level of interest in shorting Takeda Pharmaceutical Company shares can be evaluated.
Takeda Pharmaceutical Company's "short interest ratio" (SIR) is the quantity of Takeda Pharmaceutical Company shares currently shorted divided by the average quantity of Takeda Pharmaceutical Company shares traded daily (recently around 2.9 million). Takeda Pharmaceutical Company's SIR currently stands at 3.82. In other words for every 100,000 Takeda Pharmaceutical Company shares traded daily on the market, roughly 3820 shares are currently held short.
However Takeda Pharmaceutical Company's short interest can also be evaluated against the total number of Takeda Pharmaceutical Company shares, or, against the total number of tradable Takeda Pharmaceutical Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Takeda Pharmaceutical Company's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Takeda Pharmaceutical Company shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Takeda Pharmaceutical Company shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Takeda Pharmaceutical Company.
Who can travel, the quarantine and immunisation rules and everything else you need to travel to New Zealand from Singapore.
Find out what rules are in place for travel from Singapore to Fiji.
Discover the current rules on travelling to the UK from Singapore.
These are the rules to know if you’re thinking of travelling to the Bahamas from Singapore.
Who can travel, the quarantine and immunisation rules and everything else you need to travel to Indonesia from Singapore.
From who can travel to quarantine rules – we answer your questions about flying from Singapore to Canada.
Here’s what you should know about travelling to Spain from Singapore.
Compare share trading apps to find out which app has all the tools and resources you need to reach your investment goals.
Everything we know about the Didi Chuxing IPO, plus information on how to buy in.
Robinhood is expected to go public, here’s what you need to know if you’re looking to buy in from Singapore.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.